Teva’s Shared Solutions® is committed to helping your patients find affordable access to AJOVY
Patient Services PortalThe support team at CoverMyMeds® can help resolve or automatically initiate PA requests
CoverMyMeds®AJOVY is indicated for the preventive treatment of migraine in adults and is the only anti-CGRP treatment with monthly 225 mg SC and quarterly 675 mg (225 mg x 3) SC dosing options.
See the efficacy results in clinical trials for AJOVY
Teva’s Shared Solutions® is committed to helping your patients find affordable access to AJOVY
Patient Services PortalThe support team at CoverMyMeds® can help resolve or automatically initiate PA requests
CoverMyMeds®